A
Alexandre González-Rodríguez
Researcher at Autonomous University of Barcelona
Publications - 95
Citations - 861
Alexandre González-Rodríguez is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Delusional disorder & Medicine. The author has an hindex of 13, co-authored 68 publications receiving 561 citations. Previous affiliations of Alexandre González-Rodríguez include University of Basel & Rafael Advanced Defense Systems.
Papers
More filters
Journal ArticleDOI
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis
Virginia Soria,Alexandre González-Rodríguez,Elena Huerta-Ramos,Judith Usall,Jesús Cobo,Miquel Bioque,Juan David Barbero,Clemente Garcia-Rizo,Meritxell Tost,José Antonio Monreal,Javier Labad,Javier Labad +11 more
TL;DR: The use of drugs targeting hormones related to the HPA axis and sex steroids is a promising field of research that might help to improve the cognitive outcome of patients with schizophrenia, bipolar disorder and major depressive disorder in the near future.
Journal ArticleDOI
Antipsychotic Response Worsens With Postmenopausal Duration in Women With Schizophrenia.
Alexandre González-Rodríguez,Rosa Catalán,Rafael Penadés,Victoria Ruiz Cortés,Mercè Torra,Mary V. Seeman,Miquel Bernardo +6 more
TL;DR: Time since menopause was significantly negatively associated with antipsychotic response in postmenopausal schizophrenic women, suggesting a decline in antipsychotics response after menophere, and smoking and cumulative estrogen exposures were associated with improvement in negative symptoms.
Journal ArticleDOI
Influence of social cognition on daily functioning in schizophrenia: study of incremental validity and mediational effects.
Sara Martínez-Domínguez,Rafael Penadés,Barbara Segura,Alexandre González-Rodríguez,Rosa Catalán +4 more
TL;DR: The evidence underlining the importance of targeting not only social cognitive or neurocognitive functions but to combine both interventions to reveal the best daily functioning results in schizophrenia patients is added.
Journal ArticleDOI
Neuroimaging studies of cognitive remediation in schizophrenia: A systematic and critical review
Rafael Penadés,Alexandre González-Rodríguez,Rosa Catalán,Bàrbara Segura,Miquel Bernardo,Carme Junqué +5 more
TL;DR: Neuroimaging studies of cognitive remediation in patients with schizophrenia suggest a positive effect on brain functioning in terms of the functional reorganisation of neural networks.
Journal ArticleDOI
The search for new biomarkers for cognition in schizophrenia
Rafael Penadés,Clemente Garcia-Rizo,Miquel Bioque,Alexandre González-Rodríguez,Bibiana Cabrera,Gisela Mezquida,Miquel Bernardo +6 more
TL;DR: It is concluded that although there is a diversity of biomarkers focused on cognitive function in schizophrenia, BDNF is the biomarker that has accumulated the vast majority of evidence in the current literature.